(ATDN) Treatment Briefs: Nelfinavir Expanded Access

(ATDN) Treatment Briefs: Nelfinavir Expanded Access

Treatment Review No. 23 - December 1996

Nelfinavir (trade name Viracept) is a protease inhibitor made by a company called Agouron. Nelfinavir is now available to people with under 50 T4 cells who either cannot take approved protease inhibitors because of side effects, or have not responded to treatment with approved protease inhibitors. Call Agouron at (800) 621-7111 for more information.

961201
ATR023011

Always watch for outdated information. This article first appeard in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1996 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1996. AEGIS.